Medicare Enrolled
Dr. Sanjay Sharma, M.D.
Medical Oncology · Fullerton, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sharma from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sharma?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sharma
Dr. Sanjay Sharma is a medical oncology specialist in Fullerton, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sharma performed 1,038 Medicare services across 485 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sharma received a total of $771,172 from 89 pharmaceutical and/or device companies across 1908 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sharma is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 38% volume in CA
$771,172 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,038
Medicare services
Top 38% in CA for medical oncology
485
Unique beneficiaries
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~55 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
720 | $101 | $345 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
137 | $106 | $485 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
82 | $8 | $13 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
28 | $138 | $447 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $78 | $245 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
19 | $103 | $345 |
| New patient office visit, complex (60-74 min) | 15 | $177 | $591 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
14 | $103 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$771,172
Total received (2018-2024)
Avg $110,167/year across 7 years
Top 2% in CA for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
89
Companies
1,908
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$719,356 (93.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$31,235 (4.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,581 (2.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$182,104
2023
$124,135
2022
$92,909
2021
$36,581
2020
$28,389
2019
$130,211
2018
$176,842
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$107,195
AstraZeneca Pharmaceuticals LP
$29,503
Merck Sharp & Dohme LLC
$11,737
GENZYME CORPORATION
$11,083
Regeneron Healthcare Solutions, Inc.
$8,420
PFIZER INC.
$6,879
Amgen Inc.
$4,030
ARRAY BIOPHARMA INC
$875
Celgene Corporation
$247
Novartis Pharmaceuticals Corporation
$216
Lilly USA, LLC
$181
Daiichi Sankyo Inc.
$164
ABBVIE INC.
$162
E.R. Squibb & Sons, L.L.C.
$162
Janssen Biotech, Inc.
$132
Ipsen Biopharmaceuticals, Inc
$122
Incyte Corporation
$116
Astellas Pharma US Inc
$94
Alexion Pharmaceuticals, Inc.
$94
Boehringer Ingelheim Pharmaceuticals, Inc.
$76
Eisai Inc.
$73
Geron Corporation
$55
Bayer Healthcare Pharmaceuticals Inc.
$52
Deciphera Pharmaceuticals Inc.
$50
Gilead Sciences, Inc.
$48
BeiGene USA, Inc.
$42
Takeda Pharmaceuticals U.S.A., Inc.
$38
GlaxoSmithKline, LLC.
$32
Exelixis Inc.
$31
Blueprint Medicines Corporation
$29
SOBI, INC
$24
SpringWorks Therapeutics, Inc.
$24
Genentech USA, Inc.
$23
Karyopharm Therapeutics Inc.
$22
JAZZ PHARMACEUTICALS INC.
$20
Coherus Biosciences Inc.
$19
RECORDATI_RARE_DISEASES_INC.
$17
PROGENICS PHARMACEUTICALS, INC.
$16
Top 3 companies account for 81.5% of 2024 payments
All-time payments by company (2018-2024) ›
EMD Serono, Inc.
$132,893
AstraZeneca Pharmaceuticals LP
$101,538
E.R. Squibb & Sons, L.L.C.
$100,568
Amgen Inc.
$90,875
Celgene Corporation
$69,517
Merck Sharp & Dohme Corporation
$42,605
GENZYME CORPORATION
$39,308
Merck Sharp & Dohme LLC
$37,042
PFIZER INC.
$34,059
Regeneron Healthcare Solutions, Inc.
$33,227
Takeda Pharmaceuticals U.S.A., Inc.
$32,348
Eisai Inc.
$21,460
Genentech USA, Inc.
$6,963
Abbott Laboratories
$5,029
ABIOMED
$2,692
Lilly USA, LLC
$2,660
Servier Pharmaceuticals LLC
$2,470
Janssen Biotech, Inc.
$2,331
JAZZ PHARMACEUTICALS INC.
$1,967
Exelixis Inc.
$1,611
Bayer HealthCare Pharmaceuticals Inc.
$1,048
Novartis Pharmaceuticals Corporation
$1,030
ARRAY BIOPHARMA INC
$988
EISAI INC.
$793
Astellas Pharma US Inc
$651
Pharmacyclics LLC, An AbbVie Company
$519
Incyte Corporation
$380
Daiichi Sankyo Inc.
$371
Gilead Sciences, Inc.
$299
Seagen Inc.
$239
ABBVIE INC.
$234
Janssen Pharmaceuticals, Inc
$214
Ipsen Biopharmaceuticals, Inc
$197
Alexion Pharmaceuticals, Inc.
$178
Blueprint Medicines Corporation
$148
Bayer Healthcare Pharmaceuticals Inc.
$122
Boehringer Ingelheim Pharmaceuticals, Inc.
$119
Myovant Sciences Inc.
$118
TESARO, Inc.
$113
Deciphera Pharmaceuticals Inc.
$103
COMSORT, Inc
$100
Karyopharm Therapeutics Inc.
$100
Agios Pharmaceuticals, Inc.
$99
AbbVie, Inc.
$96
Pharmacyclics LLC, an AbbVie Company
$96
Blue Earth Diagnostics Limited
$87
BeiGene USA, Inc.
$81
Coherus Biosciences Inc.
$77
Rigel Pharmaceuticals, Inc.
$77
AbbVie Inc.
$76
MEDIVATION FIELD SOLUTIONS LLC
$67
AMAG Pharmaceuticals, Inc.
$66
Geron Corporation
$55
PUMA BIOTECHNOLOGY, INC.
$54
Sirtex Medical Inc
$54
Verastem, Inc.
$53
INSYS Therapeutics Inc
$48
Teva Pharmaceuticals USA, Inc.
$47
Puma Biotechnology, Inc.
$46
Foundation Medicine, Inc.
$45
Chiesi USA, Inc.
$41
Dova Pharmaceuticals
$40
Array BioPharma Inc.
$40
Clovis Oncology, Inc.
$36
TOLMAR Pharmaceuticals, Inc.
$36
Genmab U.S., Inc.
$32
GlaxoSmithKline, LLC.
$32
Taiho Oncology, Inc.
$31
Kyowa Kirin, Inc.
$27
Otsuka America Pharmaceutical, Inc.
$26
CSL Behring
$26
SOBI, INC
$24
SpringWorks Therapeutics, Inc.
$24
Tolmar, Inc.
$23
MorphoSys, US Inc.
$23
SERVIER PHARMACEUTICALS LLC
$22
TG THERAPEUTICS, INC.
$22
Mirati Therapeutics, Inc.
$22
Seattle Genetics, Inc.
$21
SANOFI PASTEUR INC.
$20
Kite Pharma, Inc.
$19
Cook Medical LLC
$19
Epizyme, Inc.,
$18
RECORDATI_RARE_DISEASES_INC.
$17
Jazz Pharmaceuticals Inc.
$17
PROGENICS PHARMACEUTICALS, INC.
$16
SANOFI-AVENTIS U.S. LLC
$16
Lexicon Pharmaceuticals, Inc.
$16
TG Therapeutics, Inc.
$14
Top 3 companies account for 43.4% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AVEIR · AYVAKIT · Abraxane · Absolute Pro vascular stent system · Afstyla · Alecensa · Aranesp · Asahi Fielder coronary guide wire · Assurity Pacemaker · Avastin · Axumin · BALVERSA · BAVENCIO · BENDEKA · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CAMZYOS · CHANTIX · COOK MEDICAL CELECT PLATINUM · COROFLOW · CYRAMZA · Cabometyx · CardioMEMS HF System · Confirm Rx · Copiktra · DARZALEX · DOPTELET · Doptelet · Durata Defibrillation ICD Lead · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EXKIVITY · Ellipse ICD · Enhertu · Epkinly · Erleada · FARESTON · FERAHEME · FORTIFY ASSURA · FOUNDATIONONE · Fabhalta · Fortify Assura · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Idelvion · Imbruvica · Impella · JAKAFI · JEMPERLI · JEVTANA · JOT DX · KENGREAL · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MITRACLIP · MONJUVI · MYLOTARG · Merlin Connectivity and Remote · Mitra Clip system · NERLYNX · NINLARO · NO PRODUCT DISCUSSED · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Optis Coronary Imaging System · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PRESSUREWIRE · PROMACTA · PYLARIFY · Padcev · Perclose ProGlide suture mediated closure system · Perjeta · Pomalyst · QINLOCK · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · REBLOZYL · RETEVMO · RYBREVANT · RYTELO · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · SYNDROS · Somatuline Depot · Stivarga · Supera peripheral stent system · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tecentriq · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Unify Assura CRT Defibrillator · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xience Sierra Coronary Stent System · Xience V coronary stent system · Xofigo · Xospata · Xtandi · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for medical oncology in CA.
Geographic Context
Medical oncologists within 10 mi
80
Per 100K population
2.5
County median income
$113,702
Nearest hospital
PROVIDENCE ST. JUDE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sharma is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 2% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sharma experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Sharma performed 720 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sharma receive payments from pharmaceutical companies?
Yes. Dr. Sharma received a total of $771,172 from 89 companies across 1,908 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sharma's costs compare to other medical oncologists in Fullerton?
Dr. Sharma's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sharma) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Fullerton
Browse medical oncologists in Fullerton ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in CA
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in CA
Which CA medical oncologists receive the most from drug and device companies.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology